Saturday, July 11, 2026

pharma · Decompensated Cirrhosis · Primary Ovarian Insufficiency

Shanghai Institute of

News and analysis for Shanghai Institute of on NovaPharmaNews — regulatory, clinical, and market coverage.

CN HQ
114 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
114
Programs
2
Drugs
4
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Shanghai Institute of — regulatory, clinical, and market coverage.

News and analysis for Shanghai Institute of on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Shanghai Institute of yet.

Back to company overview →